HCPCS code Q5106 — Inj retacrit non-esrd use. Status: Active. Effective Jan 1, 2020. Source: CMS HCPCS Level II.

Q5106

Active

Inj retacrit non-esrd use

Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Jan 1, 2020
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9097
Drug class: Erythropoiesis-Stimulating Agents

MUE — Medically Unlikely Edits

Maximum units of Q5106 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 60
Practitioner Services 60

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
00069-1305-10 Retacrit
00069-1306-10 Retacrit
00069-1307-10 Retacrit
00069-1308-10 Retacrit
00069-1309-04 Retacrit
00069-1311-10 Retacrit
00069-1318-10 Retacrit
59353-0002-10 Retacrit
59353-0003-10 Retacrit
59353-0004-10 Retacrit
59353-0010-10 Retacrit
59353-0120-10 Retacrit
59353-0220-10 Retacrit

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2020-Q1
    Inj retacrit non-esrd use